Catalogue description Committee of Inquiry into the Pharmaceutical Industry (Sainsbury Committee): Minutes, Papers and Reports

Search within or browse this series to find specific records of interest.

Date range

Details of MH 104
Reference: MH 104
Title: Committee of Inquiry into the Pharmaceutical Industry (Sainsbury Committee): Minutes, Papers and Reports

This series contains minutes and agenda of the Committee of Inquiry into the Pharmaceutical Industry and of its Figures Subcommittee, evidence submitted to it and drafts of its reports. Also includes some correspondence of members of the committee.

Date: 1964-1967
Held by: The National Archives, Kew
Legal status: Public Record(s)
Language: English

Committee of Inquiry into the Pharmaceutical Industry, 1965-1967

Physical description: 99 files and papers
Administrative / biographical background:

The Committee of Inquiry into the Pharmaceutical Industry was appointed by the Minister of Health and the Secretary of State for Scotland in May 1965, under the Chairmanship of Lord Sainsbury. Its terms of reference were as follows:- "To examine the relationship of the pharmaceutical industry in Great Britain with the National Health Service having regard to the structure of the industry, to the commercial policies of the firms comprising it, to pricing and sales promotion practices, to the effects of patents and to the relevance and value of research; and to make recommendations".

The procedure adopted by the Committee included publicity notices in the Press which invited submission of written evidence, and writing to organisations most likely to be concerned with the subject matter of the enquiry, inviting them to submit memoranda of evidence; oral evidence was also taken. Financial information from the industry was gathered by questionnaire as also was information on patents, trade marks and licences. An enquiry was conducted for the Committee by the Government Social Survey involving a number of doctors. Visits were made to factories and research establishments in the United Kingdom, Switzerland and the United States.

The report was presented to Parliament in September 1967 and was arranged in five parts: a Summary of Recommendations, The Issues, the Industry and the Health Departments, The Profitability and Operations of the Firms in the Industry; and Proposals. The Recommendations fall under the heading of Future Pricing Arrangements; Patents and Brand Names; The Medicines Commission; and Planning.

Have you found an error with this catalogue description?

Help with your research